- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Shared Decision Making Uncommon in PSA Screening
While American Urological Association and American College of Physician guidelines suggest shared-decision making in prostate specific antigen (PSA) screen testing, most patients have not had part in discussing those decisions.
While American Urological Association and American College of Physician guidelines suggest shared-decision making in prostate specific antigen (PSA) screen testing, most patients have not had part in discussing those decisions. Reuters reports:
Most men have not discussed the potential advantages and disadvantages of prostate cancer screening with their doctor, according to a new study.
Guidelines from groups including the American Urological Association and American College of Physicians call for shared decision-making when it comes to prostate specific antigen (PSA) testing, taking into account each man's values regarding screening.
"There's a lot of scientific uncertainty about its benefits and harms for any one person," said Dr. Paul Han, from the Maine Medical Center in Portland, who led the new study.
Read the full story here: http://reut.rs/16uCF9O
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
